Skip to main content
Top

Current Oncology Reports

Issue 6/2016

Content (7 Articles)

Leukemia (A Aguayo, Section Editor)

Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

Aharon Ronson, Ariella Tvito, Jacob M. Rowe

Cardio-oncology (EH Yang, Section Editor)

Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?

Joerg Herrmann

Cardio-oncology (EH Yang, Section Editor)

Exercise Training in Cancer Survivors

Christopher Chyu, Nancy Halnon

Cardio-oncology (EH Yang, Section Editor)

Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management

Michael E. Layoun, Chanaka D. Wickramasinghe, Maria V. Peralta, Eric H. Yang

Open Access Integrative Care (C Lammersfeld, Section Editor)

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

Jeffrey Crawford, Carla M. M. Prado, Mary Ann Johnston, Richard J. Gralla, Ryan P. Taylor, Michael L. Hancock, James T. Dalton

Sarcomas (SR Patel, Section Editor)

Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas

Philip Blumenfeld, Neilayan Sen, Ross Abrams, Dian Wang

Melanoma (RJ Sullivan, Section Editor)

Cell Cycle Regulation and Melanoma

Wen Xu, Grant McArthur

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine